Division of Vascular Surgery, IRCCS San Raffaele Scientific Institute, Vita-Salute University, Via Olgettina, 60, 20132, Milan, Italy.
Cardiovasc Intervent Radiol. 2020 Dec;43(12):1855-1864. doi: 10.1007/s00270-020-02636-w. Epub 2020 Aug 31.
Abdominal endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) have changed the aortic surgery, due to several advantages in terms of reduced morbidity and mortality. However, increasing rate of late complications requiring secondary procedures has been observed over time. Even if the majority of them may be treated by means of endovascular techniques, late open surgical conversion (LOSC) is required in specific situations. This paper aims to provide our single-center experience with LOSCs and an updated review of the literature. From 1995 to 2020, indications and outcomes of patients treated with LOSC for failed EVAR and TEVAR, at our institutions, were analyzed. LOSC was required to treat a broad range of complications that were classified into two main groups: "disease related" and "stent-graft (SG) related." Among the 121 patients treated with LOSC after EVAR, endoleak (75.2%) represented the most common indication. The overall 30-day mortality rate was 3.3%. A higher mortality rate was associated with infection after EVAR (p. 006). Among the 81 patients treated with LOSC after TEVAR, endoleak (32.1%) was the most common indication. The overall 30-day mortality rate was 13.6% with a higher incidence in the SG-related group (p. 02). LOSC is associated with an increased surgical complexity, in both the abdominal and thoracic area, that results in higher morbidity and mortality rates compared with standard open repair. Depending on the indication to LOSC, specific surgical maneuvers are required to improve clinical outcomes.
腹主动脉血管内修复术(EVAR)和胸主动脉血管内修复术(TEVAR)改变了主动脉手术,因为它们在降低发病率和死亡率方面具有多种优势。然而,随着时间的推移,已经观察到晚期并发症的发生率增加,需要进行二次手术。即使其中大多数并发症可以通过血管内技术治疗,在特定情况下仍需要进行晚期开放手术转换(LOSC)。本文旨在介绍我们单中心的 LOSC 经验,并对文献进行更新回顾。1995 年至 2020 年,我们分析了在我们机构接受 LOSC 治疗的 EVAR 和 TEVAR 失败患者的适应证和结局。需要进行 LOSC 以治疗广泛的并发症,这些并发症可分为两大类:“疾病相关”和“支架移植物(SG)相关”。在 121 例接受 EVAR 后 LOSC 治疗的患者中,内漏(75.2%)是最常见的适应证。总的 30 天死亡率为 3.3%。EVAR 后感染与较高的死亡率相关(p=0.006)。在 81 例接受 TEVAR 后 LOSC 治疗的患者中,内漏(32.1%)是最常见的适应证。总的 30 天死亡率为 13.6%,SG 相关组的死亡率较高(p=0.02)。LOSC 与手术复杂性增加相关,无论是在腹部还是胸部,与标准开放修复相比,其发病率和死亡率都较高。根据 LOSC 的适应证,需要特定的手术操作来改善临床结局。